Vascular Imaging

What Is the Best Imaging to Plan Treatment for Traumatic or Iatrogenic Chylothorax?

·
What Is the Best Imaging to Plan Treatment for Traumatic or Iatrogenic Chylothorax?

A 62-year-old man, three weeks post-esophagectomy for cancer, develops a persistent, large-volume left pleural effusion. The chest tube output is milky, and fluid analysis confirms chylothorax with high triglyceride levels. Conservative management with dietary modification has failed, and his nutritional status is declining. You and the thoracic surgery team are planning an intervention, but first, you need to map the lymphatic anatomy and pinpoint the site of the chyle leak. This article details the American College of Radiology (ACR) recommended imaging workflow for pretreatment planning in a patient with a confirmed traumatic or iatrogenic chylothorax. For this specific scenario, the ACR rates `Lymphangiography chest abdomen pelvis` as Usually appropriate.

Who Fits This Clinical Scenario?

This guidance applies to any adult or child with a confirmed chylothorax that has a clear traumatic or iatrogenic cause. The key inclusion criteria are:

  • Confirmed Chylothorax: Pleural fluid analysis shows triglycerides >110 mg/dL or the presence of chylomicrons.
  • Known Traumatic or Iatrogenic Etiology: The chylothorax developed after a specific event, such as thoracic surgery (e.g., esophagectomy, cardiac surgery, lung resection), neck dissection, chest trauma (blunt or penetrating), or central line placement.
  • Pretreatment Planning: The clinical goal is to obtain anatomical information to guide a specific intervention, such as thoracic duct embolization (TDE), ligation, or pleurodesis.

This workflow is distinct from the workup for chylothorax of unknown or nontraumatic origin. If your patient presents with a chylous effusion without a clear preceding injury or surgery, that constitutes a different clinical question. That scenario, which involves a broader differential including malignancy, infection (tuberculosis), and congenital abnormalities, requires a different diagnostic approach. This article specifically addresses the patient in whom the “why” is known, and the question is “where” to intervene.

What Diagnoses Are You Working Up in This Scenario?

In the setting of trauma or surgery, the differential diagnosis for chylothorax is narrow and focused on identifying the precise location and nature of the lymphatic system disruption. The goal of imaging is not to discover the cause, which is already known, but to create a roadmap for repair.

Thoracic Duct Transection or Laceration: This is the most common underlying pathology. The thoracic duct is a fragile structure that can be inadvertently injured during procedures in the neck, chest, or upper abdomen. Imaging aims to identify the exact point of disruption along its course from the cisterna chyli in the abdomen, through the aortic hiatus, and up the posterior mediastinum to its terminus in the neck.

Tributary Lymphatic Injury: Less commonly, the leak may not originate from the main thoracic duct itself but from a significant tributary vessel. This can occur with more localized trauma or surgery, such as a lung resection or mediastinal lymph node dissection. Identifying a tributary leak is critical, as the interventional approach may differ from a main duct injury.

Fistula Formation: Chronic leaks can sometimes form a fistulous tract between the injured lymphatic vessel and the pleural space. Delineating the anatomy of this tract is essential for planning a successful embolization or surgical repair, as simply targeting the presumed location of the duct may not be sufficient.

Why Is Lymphangiography the Recommended Study for This Presentation?

For planning intervention in traumatic chylothorax, the primary clinical need is to visualize the lymphatic channels, identify the leak, and understand the flow dynamics. This requires a functional and anatomical study, which is why lymphangiography is the cornerstone of the workup.

The ACR designates both conventional and MR lymphangiography as Usually appropriate. The choice between them often depends on institutional expertise and patient factors.

  • Intranodal Lymphangiography: This fluoroscopically guided procedure involves accessing inguinal lymph nodes under ultrasound guidance and injecting an oil-based contrast agent (lipiodol). The contrast opacifies the lymphatic channels, cisterna chyli, and thoracic duct, providing a dynamic roadmap of the central lymphatic system. It can directly visualize the point of contrast extravasation, confirming the leak site. The relative radiation level for an adult `Lymphangiography chest abdomen pelvis` is ☢☢☢ (1-10 mSv).
  • MR Lymphangiography: This non-ionizing radiation alternative is also rated Usually appropriate. T2-weighted sequences can visualize static, fluid-filled lymphatic channels. Dynamic contrast-enhanced techniques, often involving an intranodal or interstitial gadolinium injection, can demonstrate flow and identify leak points with high spatial resolution and without radiation exposure (Relative Radiation Level: O). This is an especially important consideration in pediatric patients.

Alternative studies are rated lower because they fail to provide the direct visualization of lymphatic channels needed for interventional planning.

  • CT of the Chest, Abdomen, and Pelvis with IV Contrast is rated May be appropriate. While CT excels at showing the consequences of the chyle leak (pleural effusion, fluid collections) and ruling out other postsurgical complications, it does not directly visualize the thoracic duct or the leak itself. It serves as an anatomical map but not a functional one. The radiation dose is also higher, with an adult RRL of ☢☢☢☢ (10-30 mSv).
  • Ultrasound of the Chest is rated Usually not appropriate for this indication. While useful for quantifying pleural fluid and guiding thoracentesis, it cannot visualize the deep lymphatic structures of the mediastinum or abdomen and offers no value in localizing a chyle leak.

While lymphangiography is the definitive study, a CT may still be performed as part of the initial postsurgical evaluation. Once you’ve decided on CT as an adjunctive study, our protocol guide covers the technique, contrast, and reading principles: CT Chest/Abdomen/Pelvis with IV Contrast.

What’s Next After Lymphangiography? Downstream Workflow

The results of the lymphangiogram directly guide the next therapeutic step, which is often performed by an interventional radiologist or thoracic surgeon in the same setting or shortly after the diagnostic study.

  • If the study is positive and shows a leak from the thoracic duct or a major tributary: The patient is a candidate for percutaneous intervention. The most common approach is thoracic duct embolization (TDE). The same access used for the diagnostic lymphangiogram (or a new access into the cisterna chyli) is used to advance a microcatheter to the site of injury, which is then sealed with coils and/or liquid embolic agents. This is a highly effective, minimally invasive treatment.
  • If the study is negative and no leak is identified: This can occur with low-output or intermittent leaks. The first step is to review the clinical picture and confirm the diagnosis of chylothorax. If the clinical suspicion remains high, a repeat lymphangiogram after a high-fat meal may provoke the leak and make it visible. If no leak can be found despite a persistent chylothorax, it may suggest a source outside the central lymphatic channels, and surgical exploration with pleurodesis may be considered.
  • If the study is indeterminate or shows complex anatomy not amenable to embolization: In some cases, the duct may be completely transected with a large gap, or the anatomy may be too tortuous for catheterization. In these situations, the lymphangiogram still provides a crucial surgical roadmap for thoracic duct ligation, a procedure where the surgeon directly ties off the duct below the site of the injury.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for traumatic chylothorax requires careful coordination between the primary team, diagnostic imaging, and interventional specialists. Here are common pitfalls to avoid:

  • Delaying the Diagnostic Study: Prolonged high-output chylothorax leads to severe malnutrition, dehydration, and immunodeficiency. Once conservative management fails (typically after 5-7 days), prompt imaging to plan for intervention is critical.
  • Relying Solely on Cross-Sectional Imaging: Ordering only a CT scan without a plan for lymphangiography is a common error. CT provides anatomical context but will not localize the leak, which is the essential information needed for TDE or ligation.
  • Inadequate Patient Preparation: For lymphangiography to be successful, the lymphatic system needs to be active. Some protocols advocate for a high-fat meal or cream prior to the procedure to maximize chyle flow and increase the conspicuity of a leak.
  • Ignoring Pediatric Dose Considerations: Children are more sensitive to radiation. While MR lymphangiography is an excellent radiation-free option, if conventional lymphangiography or CT is necessary, ensure the protocol is optimized for pediatric patients to minimize dose (ALARA principle).

If a patient’s nutritional status is rapidly deteriorating or they are developing signs of sepsis, escalate immediately to your interventional radiology and thoracic surgery colleagues to expedite the diagnostic and therapeutic procedures.

Related ACR Topics and Tools

For a comprehensive overview of imaging for all chylothorax etiologies and a comparison of different clinical scenarios, please consult our parent guide. It provides the breadth that this deep-dive article builds upon. Additional tools can help you apply these guidelines in your daily practice.

Frequently Asked Questions

Why is MR lymphangiography also ‘Usually appropriate’ if conventional lymphangiography is the classic test?

MR lymphangiography is an excellent non-ionizing radiation alternative that offers superb soft-tissue contrast and can visualize both the anatomy of the lymphatic ducts and the dynamic flow of chyle, particularly with contrast enhancement. Its ‘Usually appropriate’ rating reflects its high diagnostic utility, making it an equivalent first-line choice, especially in pediatric patients or centers with significant MRI expertise.

My patient had a CT scan that was negative. Should I still order a lymphangiogram?

Yes. A CT scan is not designed to visualize the thoracic duct or a chyle leak directly. Its primary role is to show the pleural effusion and surrounding anatomy. A ‘negative’ CT does not rule out a thoracic duct injury. If chylothorax is confirmed by fluid analysis, a lymphangiogram is the necessary next step to localize the leak for treatment planning.

What if my institution does not offer lymphangiography or thoracic duct embolization?

These are specialized procedures typically performed at tertiary or quaternary care centers with experienced interventional radiologists. If your patient has a persistent traumatic chylothorax and your facility does not offer these services, the standard of care is to arrange for transfer to a center that does.

Is there a role for lymphoscintigraphy in this traumatic scenario?

According to the ACR, lymphoscintigraphy is rated ‘May be appropriate’. This nuclear medicine study can confirm lymphatic drainage to the thorax but provides much lower spatial resolution than conventional or MR lymphangiography. It is generally not the preferred study for localizing a leak with the precision needed for embolization or surgical planning, but it can be a secondary option if other modalities are unavailable or contraindicated.

The patient’s chylothorax occurred after central line placement. Does this workflow still apply?

Yes. Chylothorax resulting from subclavian or internal jugular vein catheterization is a known iatrogenic complication, caused by direct injury to the thoracic duct near its insertion point. This falls squarely within the ‘traumatic or iatrogenic etiology’ scenario, and lymphangiography is the appropriate study to map the injury before planning an intervention.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026